Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through video calls and online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
- Referrals to patient-related programs or resources
- Donations, website, or event-related assistance
- Tobacco-related topics
- Volunteer opportunities
- Cancer Information
For medical questions, we encourage you to review our information with your doctor.
-
- Platelets May Help Breast Cancer Spread (E Battinelli)
- Triggering Signals of BRCA1 Breast Cancer (K Kessenbrock)
- ID of Biomarkers and Survivors’ QofL (S Patel)
- Screening & Genetic Risks (J Yeh)
- Breast Cancer TheoryLab Podcasts
- 3D Mini Breast Tumors (K Varley)
- Excess Weight Shortens Life (M Gaudet)
- CHC & Mammography (J Star)
- Poverty and Breast Cancer Survivors (K Kenzik)
- Improving Chemotherapy (O Sahin)
- Combo Treatment for TNBC (K Varley)
- Survivors' Risk of New Cancers (H Sung)
- Treatments Attack Cell Division (A Holland)
- High-Risk Genes and Screening (A Patel)
- Black Women & Genetic Testing (J Palmer)
- Women 65+ & Genetic Tests for Breast Cancer Risk (L Teras)
- New Risk Calculation May Affect Breast Cancer Screening (L Teras)
- ER+ Treatment in Mice (P Kenny)
- Blood DNA Monitors Metastasis Treatment (H P Ji)
- PTK6 Gene as Treatment Target (H Irie)
- Quality of Care (J Tsui)
- Time-Lapse Cell Movies (S Spencer)
- Black Men and Breast Cancer (H Sung)
- Natural Killer Cells & TNBC (R. Chakrabarti)
-
- Cancer Disparities in the US (F. Islami)
- Medicaid Eligibility Limits (J Zhao)
- Clinical Trial Treatment Cost App (L Hamel)
- Exercise & Sitting Time (E. Rees-Punia)
- Breast Cancer Treatment in Ethiopia (A. Jemal)
- Predicting the Effects of Liver Cancer (C. Wray)
- Disparities' Effect on Cancer Recurrence (M. Hassett)
- Cancer Information about LGBTQ People (B. Charlton)
- Podcasts, TheoryLab
- Better Survival Requires Better Insurance (J Zhao)
- Patients Health Insurance Tool (M. Politi)
-
- New Treatment for Neuroblastoma (A Heczey)
- Oncogenic Fusions AML (S Meshinchi)
- Medicare Expansion Improves Survival (X Han)
- Dobbs v Jackson: What to Know (X Han)
- Genetic Risks (L Teras)
- New Medulloblastoma Drugs (J Rodriguez-Blanco)
- Potential New Hope for MLL (J Grembecka)
- Increase in Brain Tumor Diagnosis (K Miller)
- Longer Life Expectancy for Survivors (J Yeh)
- Potential Target for New Osteosarcoma Drugs (C Benavente)
- At-Home Chemo for Children with HR ALL (L Ranney)
- Childhood Cancer Research Landscape Report
-
- Vitamins and Survival (J. Figueiredo and C. Um)
- Tumor-Infiltrating Neutrophils (R. Sumagin)
- Insurance, Screening, and Unemployment (S Fedewa)
- New Epigenetic Target (K Rai)
- Low Survival Rates Sub-Saharan Africa (A. Jemal)
- Podcasts, TheoryLab
- Extra Chromosomes (Aneuploidy) Effect on Cancer (J. Sheltzer)
- Aspirin and Colorectal Cancer Survival (P. Campbell)
- Colorectal Cancer Screening During COVID-19 Pandemic (J. Nodora)
- RNA Type May Help Diagnosis & Treatment of Metastatic CRC (C. Maher)
- Link Between Gluten and Colorectal Cancer (C. Um)
- Clinical Trial Looks for Best Way to Keep Survivors Exercising (H. Leach)
- Designer Virus Targets and Kills CRC Cells in Mice (S. Warner)
- Tiny Sensor in Mice May Find Cancer That's Trying to Spread (L. Hao)
- Targeting a Protein “Turned on” by Mistake (N. Gao)
-
- Keto Molecule & Colorectal Cancer (M Levy)
- Availability of Healthy Food (L Tussing-Humphreys)
- 45 Min/Day of Physical Activity (A Minihan)
- Fewer than 10K Steps/Day (A Patel)
- Yogurt & Cheese & ER- Breast Cancer (M McCullough)
- Stage 2 Clinical Trials for New Endometrial Cancer Drug (V Bae-Jump)
- Hard-to-Starve Pancreatic Cancer Cells (N Kalaany)
- Coffee Risks for Colorectal Cancer (C Um)
- Food Parasite & Brain Cancer Risk (J Hodge)
- Exercise & Quality of Life in Older Survivors (E Rees-Punia)
- 21 Metabolites Linked with Breast Cancer (Y Wang)
- Replacing Sitting May Affect Weight (E Rees-Punia)
- CPS-3 Researchers Ask People What They Eat and Check Urine Samples (Y Wang)
- Video Games Motivate Exercise? (E. Lyons)
- Food Choices and Colon Cancer Risk (P. Chandler)
- Race, Exercise & Breast Cancer (C. Dallal)
- Diet with Colorectal Cancer (M. Guinter)
-
- Stopping Smoking Earlier in Life (F Islami)
- Most with Lung Cancer Smoked (A Jemal)
- Furthering Lung Cancer Screening & Equity (S Fedewa)
- Mouse Lung Organoids for Research (C Kim)
- Quality of Life for Lung Cancer Survivors (J Temel)
- Precision Therapies for NSCLC (P Janne)
- Cancer Deaths from Smoking (F Islami)
- Lung Cancer Surgery Disparities (A Jemal)
- BRG1-Deficient Lung Cancers (C Kim)
- Yoga for Couples with Lung Cancer (K Milbury)
- Metabolic Differences as New Drug Targets (A Marcus)
-
- Gene-Testing Tools May Personalize Care (A Sood)
- Chromosome-Hoarding Ovarian Cancer Cells & Treatment (J Sheltzer)
- Machine Learning & Glowing Nanosensors (D Heller)
- New Gene Linked with Deadliest Type (C Han)
- Ovarian Cancer May Start in Fallopian Tube Cells (K Lawrenson)
- Nanoparticles as Drug Delivery for Metastases (X Lu)
- Turning Off 2 Proteins to Slow HGSC (P Kreeger)
- Targeted Light Therapy in Mice (M Bai)
- Nanoparticles, CAR T, and CRISPR (M Stephan)
- Endometriosis & Ovarian Cancer in Mice (M Wilson)
- Facts & Figures Help Policy Makers (L Torres)
- Chromosome-Hoarding Tumor Cells & Treatment (J Sheltzer)
-
- 2 New Drug Pathways to EZH2 (Q Cao)
- Proton Beam Therapy (L Nogueira)
- Survivors Who Eat More Chicken and Less Meat (Y Wang)
- Men Who Have Obesity or Who Gain 10+ Pounds After Diagnosis (Y Wang)
- Prostatectomy for Black Men Who Also Have Obesity (A Vidal)
- Medicaid Alone Doesn't Improve Prostate Cancer Care (C Filson)
- 5 Years After Recommending Against Routine PSA Tests (A Jemal)
- Toxicity of Certain Immune Cells in Bone May Present New Treatment (L Cook)
- Heart Medicines May Spur Future Prostate Treatments (I Schlaepfer)
- Genetic Tool for Prostate Cancer in Blacks (K Yamoah)
- New Test May Predict Treatment for Prostate Cancer (R Blind)
- Untreatable Prostate Cancers (W Li)
-
- UV Exposure, Melanoma, & Dark Skin Types (A. Adamson)
- Melanoma and Lipid Droplets (R. White)
- Zebrafish and Acral Melanoma (R. White)
- T-Cell Lymphoma and PD1 (J. Choi)
- New Drug Destroys Cancer-Causing Protein (C. Crews)
- Virus & Merkel Cell Skin Cancer (R. Wang)
- Non-Genetic Drug Resistance (S. Spencer)
- Hijacking the Body's Sugar (R. Wang)
- Telling about High Risk (P. Kanetsky)
- Brain Metastasis and Alzheimer’s (E. Hernando)
- Exhausted Melanoma "Killer" Cells (W. Cui)
More Information About Cancer in LGBTQ People May Help Improve Prevention, Diagnosis, and Treatment
Grantee: Brittany M. Charlton, ScD
Institution: Boston Children's Hospital
Area of Focus: Cancer Control
Grant Term: 7/1/2017 to 9/26/2022
The Challenge: People who identify as lesbian, gay, bisexual, and queer (LGBTQ) may have a higher risk of getting cancer than those who identify as heterosexual or cisgender. Potential cancer disparities in cervical, breast, lung, and other types of cancer are largely due to discrimination and other factors.
The Research: Brittany M. Charlton, ScD, is studying information from various studies, including 4 large, national studies with nearly 200,000 people, of which 15,000 identify as LGBTQ.
Since the start of her grant, Charlton has published many studies in peer-reviewed journals. Here are a few of her discoveries.
About health insurance coverage, doctor-patient relationships, and cancer screening:
- Compared to heterosexual, cisgender people, LGBTQ people are more likely to be unemployed, uninsured, lack access to health care, and delay health care—including care that’s critical to help prevent cancer and screen for it.
- Regardless of their sexual orientation, people whose health care providers knew their sexual orientation were more likely to have been encouraged to get cancer screenings compared to people whose providers didn’t know their sexual orientations.
- Lesbian women were the only subgroup that was less likely than heterosexual women to be encouraged to receive cancer preventive care, such as HPV vaccinations and Pap tests.
- Lesbian women are less likely than heterosexual women to have a Pap test, and when they are tested, the result is more likely to be abnormal.
About mammograms:
- Compared to Black heterosexual women, Black bisexual women were more likely than to have had a mammogram in the last year. In fact, Black bisexual women had the highest prevalence of having a mammogram.
- No differences were found between the receipt of a mammogram between Black lesbian women and Black heterosexual women or between Latina, lesbian women and Latina, heterosexual women.
Why Does It Matter? Charlton’s work is documenting persistent and pronounced cancer disparities among LGBTQ people. Her work points to ways that can help reduce these disparities such as training medical providers to care for all patients—particularly vulnerable populations like LGBTQ people.
Her studies are particularly helping to fill research gaps among understudied populations within the LGBTQ community, including adolescents, women, and people of color.
Charlton’s results suggest that tailored health policies, public health programs, and clinical practices are needed to raise awareness of and access to cancer prevention information and screenings based on nuanced risk factors according to sexual orientation, gender orientation, race/ethnicity, and other sources of social Inequity.